Martinez C - Search Results

1

VIP in inflammatory bowel disease: state of the art.

Abad C, Gomariz R, Waschek J, Leceta J, Martinez C, Juarranz Y, Arranz A. Abad C, et al. Among authors: martinez c. Endocr Metab Immune Disord Drug Targets. 2012 Dec;12(4):316-22. doi: 10.2174/187153012803832576. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 23094828 Review.

2

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.

Gomariz RP, Arranz A, Abad C, Torroba M, Martinez C, Rosignoli F, Garcia-Gómez M, Leceta J, Juarranz Y. Gomariz RP, et al. Among authors: martinez c. J Leukoc Biol. 2005 Aug;78(2):491-502. doi: 10.1189/jlb.1004564. Epub 2005 Apr 27. J Leukoc Biol. 2005. PMID: 15857940

3

cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.

Abad C, Juarranz Y, Martinez C, Arranz A, Rosignoli F, García-Gómez M, Leceta J, Gomariz RP. Abad C, et al. Among authors: martinez c. Inflamm Bowel Dis. 2005 Jul;11(7):674-84. doi: 10.1097/01.mib.0000171872.70738.58. Inflamm Bowel Dis. 2005. PMID: 15973123

4

Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.

Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martínez C. Arranz A, et al. Among authors: martinez c. Ann N Y Acad Sci. 2006 Jul;1070:129-34. doi: 10.1196/annals.1317.001. Ann N Y Acad Sci. 2006. PMID: 16888154

5

Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.

Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A, Juarranz Y. Leceta J, et al. Among authors: martinez c. Neuroimmunomodulation. 2007;14(3-4):134-8. doi: 10.1159/000110636. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073504 Review.

6

VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.

Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C. Arranz A, et al. Among authors: martinez c. Peptides. 2008 Jun;29(6):948-56. doi: 10.1016/j.peptides.2008.01.019. Epub 2008 Feb 7. Peptides. 2008. PMID: 18359536

7

VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.

Arranz A, Gutiérrez-Cañas I, Carrión M, Juarranz Y, Pablos JL, Martínez C, Gomariz RP. Arranz A, et al. Among authors: martinez c. Mol Immunol. 2008 Jun;45(11):3065-73. doi: 10.1016/j.molimm.2008.03.011. Epub 2008 May 2. Mol Immunol. 2008. PMID: 18452992

8

New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes.

Jimeno R, Gomariz RP, Gutiérrez-Cañas I, Martínez C, Juarranz Y, Leceta J. Jimeno R, et al. Among authors: martinez c. Immunol Cell Biol. 2010 Oct;88(7):734-45. doi: 10.1038/icb.2010.29. Epub 2010 Mar 23. Immunol Cell Biol. 2010. PMID: 20309012

9

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.

Martínez C, Juarranz Y, Gutiérrez-Cañas I, Carrión M, Pérez-García S, Villanueva-Romero R, Castro D, Lamana A, Mellado M, González-Álvaro I, Gomariz RP. Martínez C, et al. Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065. Int J Mol Sci. 2019. PMID: 31861827 Free PMC article. Review.

10

Immunology of VIP: a review and therapeutical perspectives.

Gomariz RP, Martinez C, Abad C, Leceta J, Delgado M. Gomariz RP, et al. Among authors: martinez c. Curr Pharm Des. 2001 Jan;7(2):89-111. doi: 10.2174/1381612013398374. Curr Pharm Des. 2001. PMID: 11172702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,101 results

Search Page